Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan 8;255(0):483-494.
doi: 10.1039/d4fd00123k.

Exploring the crystallisation of aspirin in a confined porous material using solid-state nuclear magnetic resonance

Affiliations

Exploring the crystallisation of aspirin in a confined porous material using solid-state nuclear magnetic resonance

Marie Juramy et al. Faraday Discuss. .

Abstract

In this study, nuclear magnetic resonance (NMR) is used to investigate the crystallisation behaviour of aspirin within a mesoporous SBA-15 silica material. The potential of dynamic nuclear polarisation (DNP) experiments is also investigated using specifically designed porous materials that incorporate polarising agents within their walls. The formation of the metastable crystalline form II is observed when crystallisation occurs within the pores of the mesoporous structure. Conversely, bulk crystallisation yields the most stable form, namely form I, of aspirin. Remarkably, the metastable form II remains trapped within the pores of mesoporous SBA-15 silica material even 30 days after impregnation, underscoring its persistent stability within this confined environment.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts to declare.

Figures

Fig. 1
Fig. 1. Schematic representation of the crystallisation of aspirin within the pores of mesoporous SBA-15 silica material (with or without wall-embedded TEMPO radicals). The mesoporous silica material is impregnated with a solution of aspirin in ethanol (0.8 M). Evaporation of solvent (ethanol) leads to crystallisation of aspirin within the pores of the material.
Fig. 2
Fig. 2. (a) 13C CPMAS NMR spectrum recorded for a mesoporous SBA-15 silica material without wall-embedded TEMPO radicals and impregnated at room temperature with a solution of aspirin in ethanol (0.8 M). The spectrum was recorded 2 days after impregnation. (b) 13C CPMAS NMR spectrum recorded for a powder sample of aspirin subsequently obtained from a solution of aspirin in ethanol. (c) 13C CPMAS NMR spectrum of commercial aspirin. All spectra were recorded without microwave irradiation and at a temperature of 98 K. Signals labelled with “*” correspond to spinning side bands.
Fig. 3
Fig. 3. 13C NMR resonances corresponding to the methyl group of the aspirin spectrum (blue curve) recorded at 98 K on a mesoporous SBA-15 silica material 2 days after impregnation with a solution of aspirin in ethanol (0.8 M). The Gaussian peaks used for the deconvolution are shown as filled grey shapes and their sum is shown as a dotted purple line. The 3 Gaussian peaks correspond to the individual 13C NMR resonances of the amorphous phase (Am), and the crystalline phases of form I and II of aspirin.
Fig. 4
Fig. 4. T -filtered 13C CPMAS NMR spectrum recorded on a mesoporous SBA-15 silica material impregnated with a 0.8 M solution of aspirin in ethanol. This experiment was recorded 2 days after material impregnation, without microwave irradiation and at a temperature of 98 K. Signals labelled with “*” correspond to spinning side bands. The 13C NMR chemical shift of the methyl group signal of forms I and II are at 19.8 ppm and 20.9 ppm, respectively.

References

    1. Bernstein J., Polymorphism in Molecular Crystals, Oxford University Press, Oxford, 2002
    1. Rodríguez-Spong B. Price C. P. Jayasankar A. Matzger A. J. Rodríguez-Hornedo N. R. Adv. Drug Delivery Rev. 2004;56:241–274. doi: 10.1016/j.addr.2003.10.005. - DOI - PubMed
    1. Lee A. Y. Erdemir D. Myerson A. S. Annu. Rev. Chem. Biomol. Eng. 2011;2:259–280. doi: 10.1146/annurev-chembioeng-061010-114224. - DOI - PubMed
    1. Woodley S. M. Day G. M. Catlow R. Philos. Trans. R. Soc., A. 2020;378:20190600. doi: 10.1098/rsta.2019.0600. - DOI - PubMed
    1. Mitchell A. G. Saville D. J. J. Pharm. Pharmacol. 1967;19:729–734. doi: 10.1111/j.2042-7158.1967.tb08024.x. - DOI - PubMed

LinkOut - more resources